Semnur Pharmaceuticals, Inc (SMNR)
NGM · Common · CUSIP 81686G113
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for SMNR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
81686G113
Market Cap
Small Cap
IPO
4/7/2022
Previous Symbol
DECA (changed 9/23/2025)
Previous Name
Denali Capital Acquisition Corp
Business: Semnur Pharmaceuticals, Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain

Company Contact

CEO
Jaisim Shah
CFO
Stephen Ma
Headquarters
960 San Antonio Road, Palo Alto, CA 94303
Phone
650-422-7515
Investor Relations
investorrelations@scilexholding.com
SEC EDGAR Filings
View filings »